论文部分内容阅读
流行性出血热(以下简称EHF)临床表现复杂,常效误诊。有报告误诊率达40.6～51.1％。我院自1986年冬开始将反向被动血凝抑制试验(以下简称RPHI)用于临床,取得了较满意的结果,现报告如下。一、材料及方法:本文30例均符合1981年西安会议关于EHF的诊断标准,均采用RPHI法检查患者血清,并作间接荧光抗体法(以下简称IFAT)和尿液葡萄球菌A蛋白协同凝集试验(以下简称SPA-CoA)两种方法进行对照。病人均于早晨空腹取血,并
Epidemic hemorrhagic fever (hereinafter referred to as EHF) clinical manifestations of complex, often misdiagnosed. Reported misdiagnosis rate of 40.6 ~ 51.1%. Our hospital from the winter of 1986 reverse passive hemagglutination inhibition test (hereinafter referred to as RPHI) for clinical use, and achieved satisfactory results, are as follows. Materials and Methods: All 30 cases were in line with the diagnostic criteria for EHF in Xi’an in 1981. All patients were tested for serum by RPHI method and co-agglutination test was performed by indirect fluorescent antibody method (hereinafter referred to as IFAT) and Staphylococcus urinary albumin A protein (Hereinafter referred to as SPA-CoA) two methods for comparison. Patients were fasting blood in the morning, and